Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 9.56M | $ 7.53M | $ 8.05M | $ 6.97M | $ 9.68M |
Total Assets | $ 49.33M | $ 46.94M | $ 43.28M | $ 42.22M | $ 13.85M |
Total Debt | $ 30.48M | $ 30.59M | $ 27.43M | $ 25.15M | $ ― |
Net Debt | $ 20.91M | $ 23.07M | $ 19.38M | $ 18.17M | $ ― |
Total Liabilities | $ 35.54M | $ 33.44M | $ 29.81M | $ 27.99M | $ 1.10M |
Stockholders Equity | $ 10.02M | $ 9.62M | $ 9.90M | $ 10.52M | $ 12.42M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |